Indeed, this co-stimulatory signal has taken relevance in different chronic inflammatory pathologies, bacterial infections, and cancer because the continuous activity of the CD28/CD86 axis may prevent T cell dysfunction and promote correct antigen clearance at the inflammatory site (65–67). The gene discussed is CD86; the disease is cancer.